Biggest News Aggregation in the World
📰 Johnm Evans News

Page 3 - Johnm Evans News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnm Evans. Real-time updates on events, politics, business and more.

Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Sold by Sectoral Asset Management Inc.

Sectoral Asset Management Inc. lessened its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,500 shares of the company’s stock after selling 2,200 shares during the quarter. Sectoral Asset Management […]
United States Nova Scotia Johnm Evans Giuseppe Ciaramella William Blair Sanfordc Bernstein

Beam Therapeutics (NASDAQ:BEAM) Price Target Lowered to $42.00 at Royal Bank of Canada

Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price target cut by Royal Bank of Canada from $50.00 to $42.00 in a report issued on Thursday, The Fly reports. BEAM has been the subject of a number of other research reports. William Blair reiterated an outperform rating on shares of Beam Therapeutics in a research […]
United States Sanfordc Bernstein William Blair Giuseppe Ciaramella Johnm Evans Raymond James Associates
Source: wkrb13.com

Royal Bank of Canada Cuts Beam Therapeutics (NASDAQ:BEAM) Price Target to $42.00

Beam Therapeutics (NASDAQ:BEAM – Get Rating) had its price objective cut by stock analysts at Royal Bank of Canada from $50.00 to $42.00 in a note issued to investors on Thursday, The Fly reports. Royal Bank of Canada’s target price points to a potential upside of 18.74% from the stock’s previous close. A number of […]
United States United Kingdom William Blair Johnm Evans Giuseppe Ciaramella Sanfordc Bernstein

Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among […]
United States Sanfordc Bernstein William Blair Johnm Evans Terry Ann Burrell Beam Therapeutics Inc
Source: wkrb13.com

Beam Therapeutics Inc. (NASDAQ:BEAM) Position Increased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC raised its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 34.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,496 shares of the company’s stock after purchasing an additional 4,199 shares […]
United States Los Angeles Johnm Evans Securities Exchange Commission Beam Therapeutics Company Profile Beam Therapeutics Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

DekaBank Deutsche Girozentrale Has $566,000 Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)

DekaBank Deutsche Girozentrale lessened its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Get Rating) by 11.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,000 shares of the company’s stock after selling 1,800 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in […]
United States Zurcher Kantonalbank Zurich Cantonalbank Johnm Evans Dekabank Deutsche Girozentrale Principal Financial Group Inc Beam Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science